vs
AtriCure, Inc.（ATRC）与CarParts.com, Inc.（PRTS）财务数据对比。点击上方公司名可切换其他公司
AtriCure, Inc.的季度营收约是CarParts.com, Inc.的1.2倍（$141.2M vs $120.4M），AtriCure, Inc.净利率更高（0.1% vs -9.6%，领先9.7%），AtriCure, Inc.同比增速更快（14.3% vs -9.8%），过去两年AtriCure, Inc.的营收复合增速更高（10.2% vs -8.6%）
AtriCure是一家专注于心房颤动及相关心脏病症治疗的医疗设备企业，研发并生产创新外科手术工具与疗法，主要服务北美、欧洲、亚太地区的医院、心脏外科中心及医疗机构，为微创心脏手术提供高效可靠的适配解决方案。
GPC是一家总部位于美国佐治亚州亚特兰大的汽车与工业零部件分销商，1928年由弗雷泽兄弟创立，目前拥有约六万名员工。除美国本土市场外，公司业务还覆盖澳大拉西亚、比利时、加拿大、法国、德国、墨西哥、荷兰、波兰及英国，旗下拥有知名汽车零部件零售商NAPA Auto Parts和工业零部件分销商Motion。
ATRC vs PRTS — 直观对比
营收规模更大
ATRC
是对方的1.2倍
$120.4M
营收增速更快
ATRC
高出24.1%
-9.8%
净利率更高
ATRC
高出9.7%
-9.6%
两年增速更快
ATRC
近两年复合增速
-8.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $141.2M | $120.4M |
| 净利润 | $108.0K | $-11.6M |
| 毛利率 | 77.4% | 33.2% |
| 营业利润率 | 23.0% | — |
| 净利率 | 0.1% | -9.6% |
| 营收同比 | 14.3% | -9.8% |
| 净利润同比 | — | 25.0% |
| 每股收益（稀释后） | $0.00 | $-0.82 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ATRCPRTS
| Q1 26 | $141.2M | — | ||
| Q4 25 | $140.5M | $120.4M | ||
| Q3 25 | $134.3M | $127.8M | ||
| Q2 25 | $136.1M | $151.9M | ||
| Q1 25 | $123.6M | $147.4M | ||
| Q4 24 | $124.3M | $133.5M | ||
| Q3 24 | $115.9M | $144.8M | ||
| Q2 24 | $116.3M | $144.3M |
净利润ATRCPRTS
| Q1 26 | $108.0K | — | ||
| Q4 25 | — | $-11.6M | ||
| Q3 25 | $-267.0K | $-10.9M | ||
| Q2 25 | $-6.2M | $-12.7M | ||
| Q1 25 | $-6.7M | $-15.3M | ||
| Q4 24 | — | $-15.4M | ||
| Q3 24 | $-7.9M | $-10.0M | ||
| Q2 24 | $-8.0M | $-8.7M |
毛利率ATRCPRTS
| Q1 26 | 77.4% | — | ||
| Q4 25 | 75.0% | 33.2% | ||
| Q3 25 | 75.5% | 33.1% | ||
| Q2 25 | 74.5% | 32.8% | ||
| Q1 25 | 74.9% | 32.1% | ||
| Q4 24 | 74.5% | 32.5% | ||
| Q3 24 | 74.9% | 35.2% | ||
| Q2 24 | 74.7% | 33.5% |
营业利润率ATRCPRTS
| Q1 26 | 23.0% | — | ||
| Q4 25 | 1.8% | — | ||
| Q3 25 | 0.2% | -7.9% | ||
| Q2 25 | -4.5% | -8.2% | ||
| Q1 25 | -4.8% | -10.3% | ||
| Q4 24 | -11.7% | -11.6% | ||
| Q3 24 | -6.4% | -6.9% | ||
| Q2 24 | -6.2% | -6.0% |
净利率ATRCPRTS
| Q1 26 | 0.1% | — | ||
| Q4 25 | — | -9.6% | ||
| Q3 25 | -0.2% | -8.5% | ||
| Q2 25 | -4.5% | -8.4% | ||
| Q1 25 | -5.5% | -10.4% | ||
| Q4 24 | — | -11.5% | ||
| Q3 24 | -6.8% | -6.9% | ||
| Q2 24 | -6.9% | -6.0% |
每股收益（稀释后）ATRCPRTS
| Q1 26 | $0.00 | — | ||
| Q4 25 | $0.04 | $-0.82 | ||
| Q3 25 | $-0.01 | $-0.19 | ||
| Q2 25 | $-0.13 | $-0.23 | ||
| Q1 25 | $-0.14 | $-0.27 | ||
| Q4 24 | $-0.33 | $-0.28 | ||
| Q3 24 | $-0.17 | $-0.17 | ||
| Q2 24 | $-0.17 | $-0.15 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $146.2M | $25.8M |
| 总债务越低越好 | $61.0M | — |
| 股东权益账面价值 | $491.7M | $53.5M |
| 总资产 | $644.0M | $184.9M |
| 负债/权益比越低杠杆越低 | 0.12× | — |
8季度趋势，按日历期对齐
现金及短期投资ATRCPRTS
| Q1 26 | $146.2M | — | ||
| Q4 25 | $167.4M | $25.8M | ||
| Q3 25 | $147.9M | — | ||
| Q2 25 | $117.8M | — | ||
| Q1 25 | $99.9M | — | ||
| Q4 24 | $122.7M | — | ||
| Q3 24 | $130.3M | — | ||
| Q2 24 | $114.0M | — |
总债务ATRCPRTS
| Q1 26 | $61.0M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $61.9M | — | ||
| Q2 25 | $61.9M | — | ||
| Q1 25 | $61.9M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $61.9M | — | ||
| Q2 24 | $61.9M | — |
股东权益ATRCPRTS
| Q1 26 | $491.7M | — | ||
| Q4 25 | $491.9M | $53.5M | ||
| Q3 25 | $476.5M | $64.2M | ||
| Q2 25 | $464.5M | $62.4M | ||
| Q1 25 | $454.6M | $72.8M | ||
| Q4 24 | $461.0M | $85.2M | ||
| Q3 24 | $465.0M | $97.2M | ||
| Q2 24 | $462.1M | $103.9M |
总资产ATRCPRTS
| Q1 26 | $644.0M | — | ||
| Q4 25 | $654.2M | $184.9M | ||
| Q3 25 | $635.4M | $200.3M | ||
| Q2 25 | $608.8M | $189.6M | ||
| Q1 25 | $591.6M | $216.5M | ||
| Q4 24 | $609.3M | $210.6M | ||
| Q3 24 | $615.1M | $227.6M | ||
| Q2 24 | $597.3M | $238.0M |
负债/权益比ATRCPRTS
| Q1 26 | 0.12× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 0.13× | — | ||
| Q2 25 | 0.13× | — | ||
| Q1 25 | 0.14× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.13× | — | ||
| Q2 24 | 0.13× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ATRC
| Appendage management | $48.4M | 34% |
| Open ablation | $39.1M | 28% |
| Other | $25.0M | 18% |
| Pain management | $22.4M | 16% |
| Minimally invasive ablation | $6.4M | 5% |
PRTS
暂无分部数据
